PTPI
Petros Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.01
+20.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-456.8%
Return on equity
-90.3%
Return on assets
-484.8%
Return on invested capital
0.00x
Asset turnover
-$3.7M
Cash from operations
$0.08
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026